Although GLP-1 receptor agonists are transforming the treatment of diabetes and obesity, gastroenterologists increasingly are being called upon to manage the side effects of these medications.
Patients taking an SSRI antidepressant with lecanemab may need additional monitoring due to the potential for increased bleeding risk with concomitant use, researchers say.